HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fei Huang Selected Research

BMS 536924

1/2011Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
1/2009The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fei Huang Research Topics

Disease

82Neoplasms (Cancer)
06/2022 - 08/2004
27Inflammation (Inflammations)
05/2022 - 09/2012
18Breast Neoplasms (Breast Cancer)
01/2021 - 05/2004
14Infections
08/2022 - 06/2003
11Neoplasm Metastasis (Metastasis)
11/2020 - 01/2005
10Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 08/2004
9Body Weight (Weight, Body)
06/2022 - 10/2010
8Neuroinflammatory Diseases
06/2022 - 08/2014
8Hypoxia (Hypoxemia)
01/2022 - 11/2005
7Asthma (Bronchial Asthma)
01/2022 - 06/2008
7Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 08/2014
6Stomach Neoplasms (Stomach Cancer)
06/2022 - 12/2016
6COVID-19
01/2022 - 01/2021
6Hepatocellular Carcinoma (Hepatoma)
05/2021 - 01/2018
6Liver Neoplasms (Liver Cancer)
01/2021 - 03/2008
5Tuberculosis (Tuberculoses)
05/2022 - 01/2019
5Leukemia
03/2022 - 06/2006
5Ischemia
01/2022 - 01/2016
5Glioma (Gliomas)
01/2019 - 01/2013
4Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 01/2015
4Necrosis
06/2022 - 09/2019
4Uterine Cervical Neoplasms (Cancer of the Cervix)
06/2022 - 01/2013
4Carcinogenesis
01/2022 - 12/2009
4Melanoma (Melanoma, Malignant)
01/2022 - 01/2009
4Insulin Resistance
01/2022 - 01/2019
4Dysbiosis
07/2021 - 11/2017
4Obesity
02/2021 - 05/2015
4Ovarian Neoplasms (Ovarian Cancer)
02/2021 - 06/2009
4Lung Neoplasms (Lung Cancer)
01/2021 - 03/2007
4Fibrosis (Cirrhosis)
01/2021 - 07/2013
4Sleep Deprivation
05/2020 - 11/2014
3Primary Myelofibrosis (Myelosclerosis)
07/2022 - 01/2018
3Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2018
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 12/2015
3Rabies (Hydrophobia)
11/2021 - 08/2020
3Pain (Aches)
10/2021 - 11/2014
3Pathologic Processes
10/2021 - 10/2013
3Pneumonia (Pneumonitis)
03/2021 - 09/2012
3Mental Disorders (Mental Disorder)
01/2021 - 12/2016
3Autistic Disorder (Autism)
11/2020 - 03/2011
3Atherosclerosis
01/2020 - 03/2008
3Prediabetic State (Prediabetes)
01/2020 - 01/2013
3Carcinoma (Carcinomatosis)
10/2019 - 01/2013

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2004
18Pharmaceutical PreparationsIBA
05/2022 - 02/2005
13Biomarkers (Surrogate Marker)IBA
10/2021 - 01/2009
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2007
9LipidsIBA
06/2022 - 12/2010
9RNA (Ribonucleic Acid)IBA
03/2021 - 05/2004
9CytokinesIBA
01/2021 - 03/2011
8Small Interfering RNA (siRNA)IBA
06/2020 - 01/2009
7Insulin (Novolin)FDA Link
01/2022 - 12/2007
7Phosphotransferases (Kinase)IBA
10/2021 - 01/2007
7DNA (Deoxyribonucleic Acid)IBA
06/2021 - 08/2004
7VaccinesIBA
05/2021 - 12/2014
6imetelstatIBA
07/2022 - 01/2018
6Messenger RNA (mRNA)IBA
01/2021 - 08/2004
5LipopolysaccharidesIBA
06/2022 - 11/2005
5CholesterolIBA
03/2022 - 01/2016
5InterleukinsIBA
02/2022 - 11/2017
5EnzymesIBA
01/2022 - 07/2003
5Biological ProductsIBA
10/2021 - 11/2010
5Cell-Free Nucleic AcidsIBA
09/2021 - 08/2017
5AntibodiesIBA
09/2021 - 09/2010
5Long Noncoding RNAIBA
01/2021 - 01/2019
5astragaloside AIBA
05/2020 - 01/2016
4Telomerase (Telomerase Reverse Transcriptase)IBA
07/2022 - 01/2018
4PowdersIBA
06/2022 - 01/2019
4Interleukin-6 (Interleukin 6)IBA
02/2022 - 11/2014
4Protein Isoforms (Isoforms)IBA
01/2022 - 06/2009
4Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 09/2012
4Triglycerides (Triacylglycerol)IBA
07/2021 - 01/2016
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 07/2010
4Polysaccharides (Glycans)IBA
10/2020 - 09/2013
4Estrogen ReceptorsIBA
01/2020 - 06/2006
4MicroRNAs (MicroRNA)IBA
01/2017 - 01/2013
4BMS 754807IBA
02/2015 - 09/2010
4Dasatinib (BMS 354825)FDA Link
05/2010 - 06/2006
3HydrogelsIBA
06/2022 - 01/2021
3Antiviral Agents (Antivirals)IBA
01/2022 - 01/2021
3Bile Acids and Salts (Bile Acids)IBA
01/2022 - 02/2021
3Complement System Proteins (Complement)IBA
01/2022 - 09/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2021 - 11/2014
3Sucrose (Saccharose)IBA
07/2021 - 01/2019
3InterferonsIBA
01/2021 - 11/2017
3Kai-Xin-SanIBA
01/2021 - 12/2016
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 06/2008
3AntigensIBA
10/2020 - 08/2004
3Gap Junction beta-1 ProteinIBA
10/2020 - 04/2015
3Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 07/2010
3CateninsIBA
01/2019 - 01/2018

Therapy/Procedure

42Therapeutics
05/2022 - 01/2005
7Drug Therapy (Chemotherapy)
10/2021 - 12/2009
5Radiotherapy
02/2022 - 12/2018
4Oral Administration
01/2020 - 09/2012
3Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 08/2020
3Length of Stay
03/2021 - 01/2018
3Intravenous Injections
01/2021 - 06/2019
3Immunotherapy
11/2020 - 01/2018
3Anesthesia
01/2020 - 10/2015